ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value per share (ACAD)

CUSIP: 004225108

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
170,450,287
Total 13F shares
155,896,219
Share change
-6,220,040
Total reported value
$2,398,194,293
Put/Call ratio
35%
Price per share
$15.38
Number of holders
257
Value change
-$102,074,875
Number of buys
120
Number of sells
125

Quarterly Holders Quick Answers

What is CUSIP 004225108?
CUSIP 004225108 identifies ACAD - ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value per share (ACAD) as of Q3 2024

As of 30 Sep 2024, ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value per share (ACAD) was held by 257 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 155,896,219 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, RTW INVESTMENTS, LP, BlackRock, Inc., STATE STREET CORP, D. E. Shaw & Co., Inc., FRED ALGER MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, Palo Alto Investors LP, and FIRST TRUST ADVISORS LP. This page lists 257 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.